Aurora Cannabis Inc. (NASDAQ:ACB) Short Interest Up 8.3% in September

Aurora Cannabis Inc. (NASDAQ:ACB) was the recipient of a large growth in short interest in September. As of September 15th, there was short interest totalling 2,730,000 shares, a growth of 8.3% from the August 31st total of 2,520,000 shares. Based on an average daily volume of 1,330,000 shares, the days-to-cover ratio is presently 2.1 days. Currently, 5.0% of the shares of the stock are sold short.

Institutional Investors Weigh In On Aurora Cannabis

Hedge funds and other institutional investors have recently modified their holdings of the stock. Cubist Systematic Strategies LLC bought a new position in shares of Aurora Cannabis during the second quarter valued at about $50,000. Cetera Advisors LLC purchased a new position in Aurora Cannabis during the 1st quarter valued at about $59,000. Toronto Dominion Bank raised its position in Aurora Cannabis by 34,356.4% during the 2nd quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock valued at $88,000 after purchasing an additional 18,896 shares during the last quarter. Concurrent Investment Advisors LLC bought a new position in Aurora Cannabis during the 1st quarter valued at approximately $90,000. Finally, Baader Bank Aktiengesellschaft lifted its holdings in Aurora Cannabis by 121.1% in the 2nd quarter. Baader Bank Aktiengesellschaft now owns 22,789 shares of the company’s stock worth $100,000 after buying an additional 12,481 shares during the period. Institutional investors own 47.63% of the company’s stock.

Aurora Cannabis Stock Up 0.7 %

Shares of ACB opened at $5.88 on Tuesday. Aurora Cannabis has a 1 year low of $2.84 and a 1 year high of $9.35. The company has a debt-to-equity ratio of 0.08, a current ratio of 3.76 and a quick ratio of 2.03. The stock has a 50 day simple moving average of $6.04 and a two-hundred day simple moving average of $5.96. The firm has a market cap of $320.73 million, a P/E ratio of -4.20 and a beta of 1.86.

Aurora Cannabis (NASDAQ:ACB) last released its earnings results on Wednesday, August 7th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.35) by $0.24. The company had revenue of $67.27 million for the quarter, compared to analyst estimates of $55.98 million. Aurora Cannabis had a negative net margin of 14.46% and a negative return on equity of 7.00%. On average, analysts forecast that Aurora Cannabis will post -0.37 earnings per share for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.